Epidemiology of onychomycosis in Crete, Greece: a 12‐year study

Onychomycosis is a chronic fungal nail infection caused by dermatophytes, yeasts or non‐dermatophyte moulds (NDMs). It occurs worldwide and accounts for about 50% of all nail disorders. The incidence of the disease and the prevalence of pathogens involved vary in different geographical areas and change with time. This study was undertaken to determine the epidemiology of onychomycosis in Crete, Greece during a 12‐year period. Mycologic nail investigation (direct microscopy and cultures) was performed in samples taken from 3317 patients with clinical suspicion of onychomycosis. Demographic characteristics, comorbidities and concurrent superficial fungal infections at other body sites were also recorded. Onychomycosis was mycologically confirmed in 547 (16.5%) patients. Fingernail onychomycosis was found in 274 (50.1%) patients, toenail onychomycosis in 271 (49.5%), and both toenail and fingernail onychomycosis in two (0.4%). Yeasts were the major causative agents, followed by dermatophytes and NDMs. Candida albicans was the most commonly isolated yeast species and Trichophyton rubrum the most common dermatophyte. Concomitant fungal skin infections were noted in 53 (19.6%) patients with toenail onychomycosis. Factors predisposing to onychomycosis were trauma, diabetes, psoriasis, peripheral circulatory insufficiency and immunosuppression. Mycological investigations are necessary to confirm clinical diagnosis and identify the pathogen, in order to select the most appropriate treatment.

[1]  B. Piraccini,et al.  Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification , 2015, Mycoses.

[2]  T. Rosen,et al.  Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape. , 2015, Journal of drugs in dermatology : JDD.

[3]  E. Segal,et al.  Onychomycosis in Israel: epidemiological aspects , 2015, Mycoses.

[4]  F. Fich,et al.  Candida Parapsilosis and Candida Guillermondii: Emerging Pathogens in Nail Candidiasis , 2014, Indian journal of dermatology.

[5]  J. Szepietowski,et al.  Health-Related Quality of Life in Patients with Nail Disorders , 2011, American journal of clinical dermatology.

[6]  M. Moazeni,et al.  Onychomycosis in Tehran: mycological study of 504 patients , 2010, Mycoses.

[7]  L. K. H. Souza,et al.  Epidemiological and mycological data of onychomycosis in Goiania, Brazil , 2010, Mycoses.

[8]  J. Szepietowski,et al.  Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. , 2006, Archives of dermatology.

[9]  F. El Sayed,et al.  Onychomycosis in Lebanon: a mycological survey of 772 patients , 2006, Mycoses.

[10]  P. Nenoff,et al.  Causative agents of onychomycosis — a retrospective study , 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[11]  Y. Tselentis,et al.  The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001 , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  R. Hay,et al.  Patients at risk of onychomycosis – risk factor identification and active prevention , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  M. Lecha,et al.  Epidemiology and clinical classification of onychomycosis , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  E. Svejgaard,et al.  Onychomycosis in Denmark: prevalence of fungal nail infection in general practice , 2004, Mycoses.

[15]  A. Vélez,et al.  Study of onychomycosis in Córdoba, Spain: Prevailing fungi and pattern of infection , 2004, Mycopathologia.

[16]  J. Faergemann,et al.  Epidemiology, clinical presentation and diagnosis of onychomycosis. , 2003, The British journal of dermatology.

[17]  J. Mahoney,et al.  The diagnosis of onychomycosis. , 2003, Dermatologic clinics.

[18]  T. Koussidou,et al.  Onychomycosis in Northern Greece during 1994–1998 , 2002, Mycoses.

[19]  A. Bouratbine,et al.  [Onychomycosis in Tunis area: epidemiological and mycological data]. , 2001, Annales de dermatologie et de venereologie.

[20]  B. Elewski,et al.  A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.

[21]  A. Rachlis,et al.  Epidemiology and prevalence of onychomycosis in HIV‐positive individuals , 2000, International journal of dermatology.

[22]  Gianni,et al.  Non‐dermatophytic onychomycosis. An understimated entity? A study of 51 cases , 2000, Mycoses.

[23]  B. Piraccini,et al.  Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. , 2000, Journal of the American Academy of Dermatology.

[24]  E. Haneke,et al.  The scope of onychomycosis: epidemiology and clinical features , 1999, International journal of dermatology.

[25]  D. Roseeuw,et al.  Achilles foot screening project: preliminary results of patients screened by dermatologists , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.

[26]  Kiraz,et al.  The epidemiology of onychomycoses in Istanbul, Turkey , 1999, Mycoses.

[27]  D. Patrick,et al.  The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. , 1999, Journal of the American Academy of Dermatology.

[28]  R. Marks,et al.  A review of the epidemiology of tinea unguium in the community , 1999, The Australasian journal of dermatology.

[29]  D. Rigopoulos,et al.  Epidemiology of onychomycosis in southern Greece , 1998, International journal of dermatology.

[30]  Gupta,et al.  Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey , 1998, The British journal of dermatology.

[31]  B. Elewski,et al.  Onychomycosis: Pathogenesis, Diagnosis, and Management , 1998, Clinical Microbiology Reviews.

[32]  B. Elewski,et al.  Onychomycosis in children: prevalence and treatment strategies. , 1997, Journal of the American Academy of Dermatology.

[33]  B. Elewski Clinical pearl: diagnosis of onychomycosis. , 1995, Journal of the American Academy of Dermatology.